North American Electroceuticals Market Size, Share and Forecast 2019-2025
North American electroceuticals market is expected to grow at a CAGR of 7.0% during the forecast period. The market growth in North America can be attributed to the rising geriatric population, frequent US FDA approvals for innovative electroceutical devices, and growing adoption of minimally invasive/non-invasive surgeries for treatment of several diseases owing to growing awareness among patients related to electroceuticals. Furthermore, according to the Heart & Stroke Foundation in Canada, 1.6 million fatalities occur every year due to stroke and at least 1.3 million Canadians live with heart disease. Moreover, the rate of adoption of advanced techniques is the highest in North America. This fact is further supporting the growth of electroceuticals market in North America.
To Request a Sample of our Report on North American Electroceuticals Market: https://www.omrglobal.com/request-sample/north-american-electroceuticals-market
The market is segmented on the basis
of product and end-user. On the basis of product, the market is segmented into
cardioverter defibrillators and cardiac pacemaker, deep brain stimulators
(DBS), spinal cord stimulators (SCS), vagus nerve stimulators, hearing aids,
and cochlear implants, and others such as sacral nerve stimulators, and
transcutaneous electrical nerve stimulators.
These players adopt various strategies in order to remain competitive in the global market. Some of the strategies followed by market players include mergers and acquisitions, product offering expansion, geographical expansion, and partnerships and collaborations. In August 2019, Stanford initiated the responsive neuromodulation to control overeating. It will study the feasibility of using NeuroPace’s RNS responsive neuromodulation system to stimulate the nucleus accumbens to control overeating in people with treatment-refractory obesity.
A
full Report of North American Electroceuticals Market is Available
at: https://www.omrglobal.com/industry-reports/north-american-electroceuticals-market
North
American Electroceuticals Market Segmentation
·
Cardioverter
Defibrillators and Cardiac Pacemaker
·
Arrhythmias
·
Deep
Brain Stimulators
·
Parkinson’s
Disease
·
Depression
·
Spinal
Cord Stimulators
·
Failed
Back Syndrome
·
Ischemia
·
Vagus
Nerve Stimulators
·
Epilepsy
·
Cochlear
Implants
·
Sensorineural
Hearing Loss
·
Others
(Sacral Nerve Stimulators, Transcutaneous Electrical Nerve Stimulators)
·
Urinary
Incontinence
·
Treatment-Resistant
Depression
By End-User
·
Hospitals
and Clinics
·
Homecare
and Other
Regional
Analysis
·
United
States
·
Canada
Company
Profiles
·
Abbott Laboratories
Inc.
·
Advanced
Bionics AG
·
Axonics
Modulation Technologies Inc.
·
Boston
Scientific Corp.
·
BioElectronics
Corp.
·
Cochlear
Ltd.
·
Demant
A/S
·
Edwards
Lifesciences Corp.
·
Getinge
AB
·
GlaxoSmithKline
PLC
·
Medtronic
PLC
·
Sonova
Holding AG
·
Zoll
Medical Corp.
1. We cover more than
15 major industries, further segmented into more than 90 sectors.
2. More than 120
countries are for analysis.
3. Over 100+ paid
data sources mined for investigation.
4. Our expert
research analysts answer all your questions before and after purchasing your
report.
For More Customized Data, Request for
Report Customization @ https://www.omrglobal.com/report-customization/north-american-electroceuticals-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company
known for its crisp and concise reports. The company is equipped with an
experienced team of analysts and consultants. OMR offers quality syndicated
research reports, customized research reports, consulting and other research-based
services.
For
More Information, Visit Orion Market Research
Media
Contact:
Company
Name: Orion Market Research
Contact
Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact
no: +91 7803040404
Comments
Post a Comment